Health technology in the United States

Wearable Medical Devices Give Patients the Ability to be More Independent

Retrieved on: 
Thursday, July 16, 2020

In recent years, a more patient-centered approach has become a key enabler in the adoption of medical wearables.

Key Points: 
  • In recent years, a more patient-centered approach has become a key enabler in the adoption of medical wearables.
  • These devices place both the responsibility and control into the patient's hand, in the case of a smartwatch, to track their own health data and vital signs.
  • Recently, the Stanford Healthcare Innovation Lab launched a study with the goal of determine if information from wearable devices, like Fitbit and Apple Watch, can be used to track infectious diseases.
  • About Nemaura Medical, Inc.: Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, and proBEAT.

Impact of COVID-19 on the Global Healthcare Market, 2020 - Presents Key Growth Opportunities in Life Sciences, Medical Technologies, Digital Health, and Medical Imaging Industries

Retrieved on: 
Tuesday, July 7, 2020

This study provides actionable predictions and growth opportunities for major healthcare segments and markets during and after the pandemic.

Key Points: 
  • This study provides actionable predictions and growth opportunities for major healthcare segments and markets during and after the pandemic.
  • This disruption has created multiple opportunities along the healthcare value chain for both incumbents and established market participants.
  • The research service covers Pharmaceuticals and biotech, in vitro diagnostics, medical technologies, medical imaging, and healthcare IT.
  • The scope of this study is global, and it covers all 5 major healthcare sectors: pharmaceuticals, medical devices, patient monitoring, medical imaging, in vitro diagnostics, and healthcare IT.

Genome Medical Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Development

Retrieved on: 
Wednesday, July 1, 2020

The funds will specifically support the accelerated development of the Genome Care DeliveryTM technology platform to address the rapid growth in virtual care needs and the shortage of genomic health care experts.

Key Points: 
  • The funds will specifically support the accelerated development of the Genome Care DeliveryTM technology platform to address the rapid growth in virtual care needs and the shortage of genomic health care experts.
  • Existing investors, founders and additional growth partners also participated in this financing, bringing the total capital raised since Genome Medical was founded in 2016 to $60 million.
  • "We are pleased to partner with Samsung Catalyst Fund to forge consumer digital health technology together with genomic data and clinical genetics expertise to transform health care."
  • Genome Medical is a national telegenomics technology, services and strategy company bringing genomic medicine to everyday care.

Nemaura Medical CEO to Participate in Investor Webinar and Q&A Session on July 7, 2020

Retrieved on: 
Tuesday, June 23, 2020

A live Q&A session with Dr. Chowdhury will follow the presentation.

Key Points: 
  • A live Q&A session with Dr. Chowdhury will follow the presentation.
  • To register for the free webinar, please visit: https://www.redchip.com/corporate/webinar_register/64
    Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, and proBEAT.
  • Nemaura is planning to submit a PMA application for sugarBEAT during the second quarter of 2020 for FDA review of this device under medical device regulations.
  • proBEAT comprises a non-invasive glucose monitor and a digital healthcare subscription service and is due to be launched in the US as a general wellness product.

Align Technology Announces Partnership With MedTech Innovator Asia Pacific, Industry’s Leading Nonprofit Startup Accelerator

SAN JOSE, Calif., LOS ANGELES, and SINGAPORE, June 18, 2020 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced its partnership with MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry.

Key Points: 
  • SAN JOSE, Calif., LOS ANGELES, and SINGAPORE, June 18, 2020 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDAQ: ALGN) today announced its partnership with MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry.
  • MedTech Innovator matches healthcare industry leaders with innovative medtech startups for mentorship and support.
  • Align Technology will work with MedTech Innovator Asia Pacific to mentor and foster the growth of promising early to mid-stage companies selected for the 2020 Showcase program and provide financial support to MedTech Innovator.
  • Based in Los Angeles, Calif., MedTech Innovator is the premier nonprofit startup accelerator in the medical technology industry.

Nemaura Participated as Guest Speaker at DiabetesMine™ D-Data ExChange 2020

Retrieved on: 
Tuesday, June 16, 2020

Dr Schaebsdau discussed the versatility of the platform for continuous non-invasive monitoring, which includes temperature monitoring and monitoring other analytes such as lactate and alcohol.

Key Points: 
  • Dr Schaebsdau discussed the versatility of the platform for continuous non-invasive monitoring, which includes temperature monitoring and monitoring other analytes such as lactate and alcohol.
  • The DiabetesMine D-Date Virtual ExChange is held biannually.
  • Nemaura Medical Inc. (NMRD) is a medical technology company developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT, and proBEAT.
  • Nemaura is planning to submit a PMA application for sugarBEAT during the second quarter of 2020 for FDA review of this device under medical device regulations.

WellSky Wins 2020 MedTech Breakthrough Award for Digital Health Innovation

Retrieved on: 
Monday, June 8, 2020

LOS ANGELES, June 8, 2020 /PRNewswire-PRWeb/ -- MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, today announced that WellSky , a leading global health and community care technology company, has been selected as the winner of its "Best Predictive Analytics Solution" award for the WellSky CareInsights platform in the fourth annual MedTech Breakthrough Awards program.

Key Points: 
  • LOS ANGELES, June 8, 2020 /PRNewswire-PRWeb/ -- MedTech Breakthrough , an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market, today announced that WellSky , a leading global health and community care technology company, has been selected as the winner of its "Best Predictive Analytics Solution" award for the WellSky CareInsights platform in the fourth annual MedTech Breakthrough Awards program.
  • This 2020 MedTech Breakthrough Award clearly demonstrates WellSky's continued commitment to innovation, and we're proud to earn this recognition as we prioritize our clients' success."
  • "Predictive analytics are increasingly important for providers as health care continues to shift from fee-for-service payment models to value-based care," said James Johnson, managing director, MedTech Breakthrough.
  • We are thrilled to recognize them with our 'Best Predictive Analytics Solution' award for their incredibly versatile WellSky CareInsights solutions that break through in the crowded digital health and medical technology landscape."

Pria by BLACK+DECKER Named 2020 MedTech Breakthrough Award Winner

Retrieved on: 
Tuesday, June 2, 2020

BOSTON, June 2, 2020 /PRNewswire/ -- Pria by BLACK+DECKER , a new automated medication management device and the first direct-to-consumer product from STANLEY Healthcare , today announced that it has been awarded the 2020 MedTech Breakthrough Award for the Best New Technology Solution for Medication Management.

Key Points: 
  • BOSTON, June 2, 2020 /PRNewswire/ -- Pria by BLACK+DECKER , a new automated medication management device and the first direct-to-consumer product from STANLEY Healthcare , today announced that it has been awarded the 2020 MedTech Breakthrough Award for the Best New Technology Solution for Medication Management.
  • The MedTech Breakthrough Awards celebrate the world's most outstanding Digital Health and Medical Technology products, services and companies around the world.
  • "We are honored to receive this award and to be recognized among such incredible leaders in the medical technology space," said Sean O'Brien, director at STANLEY Healthcare.
  • More than 3,750 companies were nominated for the 2020 MedTech Breakthrough Awards.

Foldax Wins 2020 MedTech Breakthrough Award for Cardiovascular Technology Innovation

Retrieved on: 
Monday, June 1, 2020

Foldax announced today that MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, has selected its Tria LifePolymer heart valve technology as the winner of its Medical Device Engineering Breakthrough Award in the fourth annual MedTech Breakthrough Awards program.

Key Points: 
  • Foldax announced today that MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market, has selected its Tria LifePolymer heart valve technology as the winner of its Medical Device Engineering Breakthrough Award in the fourth annual MedTech Breakthrough Awards program.
  • While heart valve replacement has been performed for over 60 years, Foldaxs Tria heart valve made with LifePolymer is the first true 'breakthrough' heart valve developed in decades.
  • Our Medical Device Engineering Breakthrough Award is a marquee designation for our annual program and we congratulate Foldax on this monumental achievement with a well-deserved 2020 MedTech Breakthrough Award.
  • Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people.

Hikma receives FDA approval for its generic Vascepa®

Retrieved on: 
Friday, May 22, 2020

Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world.

Key Points: 
  • Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world.
  • For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them.
  • We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world.
  • For more information, please visit: www.hikma.com
    1 Vascepa is a registered trademark of Amarin Pharmaceuticals Ireland Limited.